These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 2865155)

  • 1. Side-effects of beta-blockers assessed using visual analogue scales.
    Lewis RV; Jackson PR; Ramsay LE
    Eur J Clin Pharmacol; 1985; 28 Suppl():93-6. PubMed ID: 2865155
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Side-effects of beta-adrenoceptor blocking drugs assessed by visual analogue scales.
    Lewis RV; Jackson PR; Ramsay LE
    Br J Clin Pharmacol; 1985 Feb; 19(2):255-7. PubMed ID: 2859044
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Raynaud's phenomenon as side effect of beta-blockers in hypertension.
    Marshall AJ; Roberts CJ; Barritt DW
    Br Med J; 1976 Jun; 1(6024):1498-9. PubMed ID: 6109
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative tolerability of labetalol versus propranolol, atenolol, pindolol, metoprolol, and nadolol.
    Burris JF; Goldstein J; Zager PG; Sutton JM; Sirgo MA; Plachetka JR
    J Clin Hypertens; 1986 Sep; 2(3):285-93. PubMed ID: 2878065
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Measuring side-effects of beta-adrenoceptor antagonists: a comparison of two methods.
    Lewis RV; Jackson PR; Ramsay LE
    Br J Clin Pharmacol; 1985 Jun; 19(6):826-8. PubMed ID: 2862895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Iatrogenic dermatoses caused by beta-blocking drugs].
    Alinovi A; Branchetti A; Barella PA
    G Ital Dermatol Venereol; 1983; 118(6):341-8. PubMed ID: 6143722
    [No Abstract]   [Full Text] [Related]  

  • 7. [Hallucinations and vivid dreams by use of metoprolol].
    Ahmed AI; van Mierlo PJ; van Waarde JA; Jansen PA
    Tijdschr Psychiatr; 2010; 52(2):117-21. PubMed ID: 20146183
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Central nervous system side-effects with hydrophilic and lipophilic beta-blockers.
    Westerlund A
    Eur J Clin Pharmacol; 1985; 28 Suppl():73-6. PubMed ID: 2865153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantification of side-effects of beta-adrenoceptor blockers using visual analogue scales.
    Lewis RV; Jackson PR; Ramsay LE
    Br J Clin Pharmacol; 1984 Sep; 18(3):325-30. PubMed ID: 6148958
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors relating to the beta blocker withdrawal syndrome.
    Henderson A; Sheridan D; Ross J; Lewis M
    Ann Acad Med Singap; 1981 Oct; 10(4 Suppl):25-8. PubMed ID: 6124208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The relative antihypertensive potency of propranolol, oxprenolol, atenolol, and metoprolol given once daily. A double-blind, crossover, placebo-controlled study in ambulatory patients.
    Ravid M; Lang R; Jutrin I
    Arch Intern Med; 1985 Jul; 145(7):1321-3. PubMed ID: 4015285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CNS-related side-effects with metoprolol and atenolol.
    Cove-Smith JR; Kirk CA
    Eur J Clin Pharmacol; 1985; 28 Suppl():69-72. PubMed ID: 4054193
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Letter: Raynaud's phenomenon as side effect of beta-blockers.
    Marshall A; Barritt DW; Roberts CJ
    Br Med J; 1976 Jul; 2(6030):301. PubMed ID: 8186
    [No Abstract]   [Full Text] [Related]  

  • 14. Depressed melatonin secretion in patients with nightmares due to beta-adrenoceptor blocking drugs.
    Brismar K; Mogensen L; Wetterberg L
    Acta Med Scand; 1987; 221(2):155-8. PubMed ID: 2884812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diverse pharmacological properties, trial results, comorbidity prescribing and neural pathophysiology suggest European hypertension guideline downgrading of beta-blockers is not justified.
    Esler M; Kjeldsen SE; Pathak A; Grassi G; Kreutz R; Mancia G
    Blood Press; 2022 Dec; 31(1):210-224. PubMed ID: 36029011
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A meta-analysis of 94,492 patients with hypertension treated with beta blockers to determine the risk of new-onset diabetes mellitus.
    Bangalore S; Parkar S; Grossman E; Messerli FH
    Am J Cardiol; 2007 Oct; 100(8):1254-62. PubMed ID: 17920367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Lipoprotein metabolism and beta receptor blockers].
    Schauer UJ; Schauer I
    Z Gesamte Inn Med; 1987 Apr; 42(8):201-5. PubMed ID: 2888241
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison between atenolol and metoprolol in respect of central nervous system side effects.
    Kirk CA; Cove-Smith R
    Postgrad Med J; 1983; 59 Suppl 3(689):161-3. PubMed ID: 6647201
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beta-blocker effects on sexual function in normal males.
    Rosen RC; Kostis JB; Jekelis AW
    Arch Sex Behav; 1988 Jun; 17(3):241-55. PubMed ID: 2900627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of beta-adrenoceptor blocking drugs in hyperthyroidism.
    Feely J; Peden N
    Drugs; 1984 May; 27(5):425-46. PubMed ID: 6144501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.